Thyroid Tumors in Pediatric Age

Thyroid Tumors in Pediatric Age

Introduction

Thyroid tumors in the pediatric population are relatively uncommon, accounting for approximately 3% of all childhood malignancies. However, they represent a significant challenge in terms of diagnosis, management, and long-term follow-up. Thyroid tumors in children and adolescents can have diverse presentations and etiologies, ranging from benign lesions to aggressive malignancies. This comprehensive review aims to provide medical professionals with an in-depth understanding of thyroid tumors in the pediatric age group, including epidemiology, clinical presentation, diagnostic workup, and treatment modalities.

Epidemiology

The incidence of thyroid tumors in children and adolescents varies across different geographic regions and populations. According to epidemiological studies, the annual incidence of pediatric thyroid cancer ranges from 0.5 to 1.2 cases per million children. The peak incidence is observed in adolescents, particularly females, with a female-to-male ratio of approximately 3:1.

Thyroid tumors in pediatric patients can be classified into several types, with papillary thyroid carcinoma (PTC) being the most common, accounting for approximately 90% of all cases. Follicular thyroid carcinoma (FTC) and medullary thyroid carcinoma (MTC) are less common, while anaplastic thyroid carcinoma (ATC) is exceedingly rare in the pediatric population.

Clinical Presentation

The clinical presentation of thyroid tumors in children and adolescents can vary depending on the tumor type, size, and extent of disease. The most common presenting symptom is a palpable neck mass, which may be associated with local compressive symptoms such as dysphagia, dyspnea, or hoarseness. Other possible presenting symptoms include neck pain, lymphadenopathy, and, in some cases, symptoms related to thyroid hormone imbalance (hyperthyroidism or hypothyroidism).

It is essential to note that thyroid tumors in children and adolescents can present differently from those in adults. For instance, pediatric patients with PTC are more likely to present with advanced disease, including lymph node metastases and extrathyroidal extension, compared to their adult counterparts.

Diagnostic Workup

The diagnostic workup for suspected thyroid tumors in the pediatric age group involves a combination of clinical evaluation, imaging studies, and laboratory tests.

Clinical Evaluation

A thorough physical examination, including careful palpation of the neck for masses or lymphadenopathy, is crucial. Additionally, assessing for symptoms such as dysphagia, dyspnea, or voice changes can provide valuable information regarding the extent of disease.

Imaging Studies

Ultrasonography (US) is the imaging modality of choice for the initial evaluation of thyroid nodules in children. It provides valuable information about the size, location, and characteristics of the nodule(s), as well as the presence of suspicious features such as microcalcifications, irregular margins, or abnormal vascularity. Additionally, US can guide fine-needle aspiration (FNA) biopsy, which is essential for cytological evaluation.

In cases of suspected advanced disease or metastases, other imaging modalities such as computed tomography (CT) or magnetic resonance imaging (MRI) may be indicated to assess the extent of local and regional spread, as well as the presence of distant metastases.

Laboratory Tests

Laboratory tests play a crucial role in the diagnostic workup of thyroid tumors in children and adolescents. Thyroid function tests, including measurements of thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3), can help assess the functional status of the thyroid gland and guide further management.

In cases of suspected MTC, serum calcitonin levels should be measured, as elevated calcitonin levels can aid in the diagnosis and follow-up of MTC.

Additionally, genetic testing may be indicated in certain cases, particularly in patients with a family history of thyroid cancer or associated syndromes, such as multiple endocrine neoplasia (MEN) syndromes.

Treatment Modalities

Surgical Management

Surgery remains the mainstay of treatment for thyroid tumors in the pediatric population. The extent of surgery depends on the tumor type, size, and extent of disease.

For well-differentiated thyroid carcinomas, such as PTC and FTC, the standard surgical approach is total thyroidectomy with central neck dissection. This approach aims to remove the primary tumor and any involved lymph nodes in the central compartment. In cases of lateral neck metastases, selective lateral neck dissection may be indicated.

For MTC, the recommended surgical approach is total thyroidectomy with central and bilateral neck dissection, as MTC has a higher propensity for lymph node metastases.

Surgical management of ATC is often challenging due to the aggressive nature of the disease. However, in selected cases, surgical resection may be considered as part of a multimodal treatment approach.

Radioactive Iodine (RAI) Therapy

RAI therapy plays a crucial role in the management of well-differentiated thyroid carcinomas, such as PTC and FTC, in the pediatric population. It is typically administered as an adjuvant therapy following surgery to ablate residual thyroid tissue and treat potential micrometastatic disease.

The optimal timing and dosage of RAI therapy in pediatric patients are subject to ongoing research and debate. Generally, RAI therapy is recommended for patients with high-risk features, such as extrathyroidal extension, lymph node metastases, or distant metastases.

It is important to note that RAI therapy in children and adolescents carries potential risks, including adverse effects on fertility, salivary gland dysfunction, and an increased risk of secondary malignancies. Therefore, a careful risk-benefit analysis and appropriate counseling are essential before proceeding with RAI therapy.

External Beam Radiation Therapy (EBRT)

EBRT may be considered as a component of multimodal therapy in selected cases of thyroid cancer in the pediatric population. It is typically reserved for patients with locally advanced or metastatic disease that is not amenable to surgery or RAI therapy.

EBRT can be used as an adjuvant therapy following surgery to improve locoregional control or as a palliative measure to alleviate symptoms associated with unresectable disease.

However, the potential long-term adverse effects of EBRT, such as growth impairment, endocrinopathies, and the risk of secondary malignancies, must be carefully weighed against the potential benefits.

Systemic Therapy

Systemic therapy, including targeted molecular therapies and chemotherapy, may be considered in specific cases of advanced or refractory thyroid cancer in the pediatric population.

Targeted molecular therapies, such as tyrosine kinase inhibitors (TKIs) and multi-kinase inhibitors, have shown promising results in the treatment of advanced or metastatic thyroid cancers that are refractory to conventional therapies. However, their use in the pediatric population is still limited, and further research is needed to establish their safety and efficacy profiles.

Chemotherapy may be considered in cases of ATC or poorly differentiated thyroid carcinomas that are unresponsive to other treatment modalities. However, the potential toxicities and long-term adverse effects of chemotherapy must be carefully considered in the pediatric population.

Long-term Follow-up and Surveillance

Long-term follow-up and surveillance are crucial components of the management of thyroid tumors in the pediatric population. Patients should undergo regular physical examinations, thyroid function tests, and imaging studies (such as US or whole-body scans) to monitor for disease recurrence or progression.

In addition to monitoring for disease-related outcomes, it is essential to address the potential long-term effects of treatment modalities, such as growth and development issues, endocrinopathies, fertility problems, and the risk of secondary malignancies. Appropriate counseling, supportive care, and multidisciplinary management involving endocrinologists, fertility specialists, and psychosocial support services are crucial for optimizing the overall well-being of these patients.

Genetic Considerations and Familial Syndromes

Thyroid tumors in the pediatric population can be associated with certain genetic conditions and familial syndromes. Understanding these associations is essential for early identification, genetic counseling, and appropriate management.

MTC is strongly associated with multiple endocrine neoplasia type 2 (MEN2) syndromes, which are caused by germline mutations in the RET proto-oncogene. Patients with MEN2 syndromes are at an increased risk of developing MTC, as well as other endocrine tumors such as pheochromocytomas and hyperparathyroidism.

Familial adenomatous polyposis (FAP) is another hereditary syndrome associated with an increased risk of thyroid tumors, particularly cribriform-morular variant of PTC. Patients with FAP should undergo regular thyroid screening and surveillance.

Additionally, other genetic conditions, such as PTEN hamartoma tumor syndrome (PHTS) and Cowden syndrome, have been linked to an increased risk of thyroid tumors, particularly follicular thyroid carcinomas.

Genetic testing and counseling should be considered for patients with a family history of thyroid cancer or associated syndromes. Early identification and appropriate management can significantly improve outcomes and reduce the risk of disease progression.

Psychosocial Considerations

The diagnosis and treatment of thyroid tumors in the pediatric population can have significant psychosocial implications for both the patients and their families. The potential long-term effects of treatment, such as physical changes, fertility concerns, and the risk of recurrence, can contribute to emotional distress, anxiety, and impact quality of life.

Psychosocial support and counseling should be integrated into the overall care plan for these patients. Addressing emotional and psychological needs, promoting coping strategies, and providing resources for educational and vocational support can help minimize the psychosocial burden associated with thyroid tumors in the pediatric age group.

Additionally, support groups and peer-to-peer interactions can be beneficial for patients and their families, enabling them to share experiences, gain insights, and receive emotional support from others facing similar challenges.

Further Reading

Tags:

Powered by Blogger.